JP2005526085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526085A5 JP2005526085A5 JP2003575997A JP2003575997A JP2005526085A5 JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5 JP 2003575997 A JP2003575997 A JP 2003575997A JP 2003575997 A JP2003575997 A JP 2003575997A JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- quinolin
- imidazo
- antigen
- amine derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0206461.6A GB0206461D0 (en) | 2002-03-19 | 2002-03-19 | Improvements in vaccination |
| PCT/EP2003/002878 WO2003077944A1 (en) | 2002-03-19 | 2003-03-18 | Improvements in vaccination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005526085A JP2005526085A (ja) | 2005-09-02 |
| JP2005526085A5 true JP2005526085A5 (https=) | 2006-03-30 |
Family
ID=9933281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575997A Pending JP2005526085A (ja) | 2002-03-19 | 2003-03-18 | ワクチン接種の改良 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050143284A1 (https=) |
| EP (1) | EP1485125A1 (https=) |
| JP (1) | JP2005526085A (https=) |
| AU (1) | AU2003212369A1 (https=) |
| CA (1) | CA2479315A1 (https=) |
| GB (1) | GB0206461D0 (https=) |
| WO (1) | WO2003077944A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1487485T3 (da) * | 2002-03-19 | 2011-03-14 | Powderject Res Ltd | Imidazoquinolinadjuvanser til DNA-vacciner |
| MXPA05006740A (es) | 2002-12-20 | 2005-10-05 | 3M Innovative Properties Co | Imidazoquinolinas arilo-sustituidas. |
| US7731967B2 (en) | 2003-04-30 | 2010-06-08 | Novartis Vaccines And Diagnostics, Inc. | Compositions for inducing immune responses |
| CA2534625A1 (en) * | 2003-08-05 | 2005-02-24 | 3M Innovative Properties Company | Infection prophylaxis using immune response modifier compounds |
| AU2004266162A1 (en) * | 2003-08-25 | 2005-03-03 | 3M Innovative Properties Company | Immunostimulatory combinations and treatments |
| CA2540541C (en) | 2003-10-03 | 2012-03-27 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| CN1889963A (zh) * | 2003-10-10 | 2007-01-03 | 宝德杰克特疫苗有限公司 | 方法 |
| WO2005051317A2 (en) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| WO2006084251A2 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
| ES2577514T3 (es) | 2005-08-22 | 2016-07-15 | The Regents Of The University Of California | Antagonistas de TLR |
| EA200800782A1 (ru) | 2005-09-09 | 2008-08-29 | Коли Фармасьютикал Груп, Инк. | ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| KR20080083270A (ko) | 2005-11-04 | 2008-09-17 | 콜레이 파마시티컬 그룹, 인코포레이티드 | 하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법 |
| WO2007106854A2 (en) | 2006-03-15 | 2007-09-20 | Coley Pharmaceutical Group, Inc. | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods |
| US8088788B2 (en) | 2006-03-15 | 2012-01-03 | 3M Innovative Properties Company | Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods |
| EP2029597A4 (en) | 2006-05-31 | 2011-11-23 | Univ California | purine analogs |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| ES2552471T3 (es) | 2007-02-07 | 2015-11-30 | The Regents Of The University Of California | Conjugados de agonistas de TLR sintéticos y usos de los mismos |
| EP3067048B1 (en) | 2007-12-07 | 2018-02-14 | GlaxoSmithKline Biologicals SA | Compositions for inducing immune responses |
| WO2010088924A1 (en) | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL105325A (en) * | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
| US6558951B1 (en) * | 1999-02-11 | 2003-05-06 | 3M Innovative Properties Company | Maturation of dendritic cells with immune response modifying compounds |
| GB0023008D0 (en) * | 2000-09-20 | 2000-11-01 | Glaxo Group Ltd | Improvements in vaccination |
-
2002
- 2002-03-19 GB GBGB0206461.6A patent/GB0206461D0/en not_active Ceased
-
2003
- 2003-03-18 EP EP03708257A patent/EP1485125A1/en not_active Withdrawn
- 2003-03-18 CA CA002479315A patent/CA2479315A1/en not_active Abandoned
- 2003-03-18 JP JP2003575997A patent/JP2005526085A/ja active Pending
- 2003-03-18 AU AU2003212369A patent/AU2003212369A1/en not_active Abandoned
- 2003-03-18 WO PCT/EP2003/002878 patent/WO2003077944A1/en not_active Ceased
- 2003-03-18 US US10/507,055 patent/US20050143284A1/en not_active Abandoned
-
2008
- 2008-01-08 US US11/970,738 patent/US20080188469A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005526085A5 (https=) | ||
| CN105491982B (zh) | 用于增强透皮递送的肽 | |
| DK1509521T3 (da) | 1H-Imidazol[4,5-c]quinolinderivater til behandling af proteinkinaseafhænige sygdomme | |
| JP2005537234A5 (https=) | ||
| AR035586A1 (es) | Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn | |
| BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
| EA200601253A1 (ru) | Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения | |
| WO2015024667A8 (en) | Method for increasing expression of rna-encoded proteins | |
| JP2007534728A5 (https=) | ||
| IL180101A (en) | Isolated peptides, peptide complex / mhc class – i, peptide-encoded nucleic acid sequences, immune-containing peptides or nucleic acid sequences and their use in drug preparation | |
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| CA2514224A1 (en) | Liquid pharmaceutical formulations of palonosetron | |
| AR035867A1 (es) | Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e | |
| ITMI20031617A1 (it) | Microcapsule a doppio strato di polisaccaridi utilizzabili | |
| WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin | |
| IL173369A (en) | Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells | |
| WO2005084306A3 (en) | Immunogenic compositions for chlamydia pneunomiae | |
| EP1491210A4 (en) | THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES | |
| DK1173476T3 (da) | Funktionelle sojabönneproteiner | |
| EA200400591A1 (ru) | СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1 | |
| HUP0400340A2 (hu) | Polipeptidek immunogenitásának csökkentésére szolgáló eljárások | |
| NO20053788L (no) | Anvendelse av lupin-konglutin for behandlingen av type II diabetes. | |
| DE60112584D1 (de) | Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit | |
| EP1583545A4 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE | |
| MXPA05012826A (es) | Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen. |